The glucagon-like peptide-1 (GLP-1) drugs poised to conquer obesity

被引：0
|
作者：
Yin, Jun [1 ]
Liu, Yuexing [1 ]
Jia, Weiping [1 ,2 ]
机构：
[1] Department of Endocrinology and Metabolism, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine, Shanghai,200233, China
[2] Institute for Proactive Healthcare, Shanghai Jiao Tong University, Shanghai,200030, China
来源：
Chinese Science Bulletin | 2024年 / 69卷 / 35期
关键词：
D O I：
10.1360/TB-2024-0417
中图分类号：
学科分类号：
摘要：
43
引用
收藏
页码：5094 / 5099
相关论文
共 50 条
  • [11] Glucagon-like peptide-1 drugs Use of GLP-1 analogues needs great caution
    Yudkin, John S.
    Lehman, Richard
    Krumholz, Harlan M.
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [12] Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): The role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress
    Bojanowska, E
    MEDICAL SCIENCE MONITOR, 2005, 11 (08): : RA271 - RA278
  • [13] Insulin as a feedback regulator of glucagon-like peptide-1 (GLP-1) release?
    Brunn, C
    Schloos, J
    Lemansky, P
    Sewing, S
    Mest, HJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 : U59 - U59
  • [14] Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes
    Luque, MA
    González, N
    Márquez, L
    Acitores, A
    Redondo, A
    Morales, M
    Valverde, I
    Villanueva-Peñacarrillo, ML
    JOURNAL OF ENDOCRINOLOGY, 2002, 173 (03) : 465 - 473
  • [15] Description and application of a novel glucagon-like peptide-1 (GLP-1) radioimmunoassay
    Lelesz, B.
    Toth, G. K.
    Peitl, B.
    Hegedus, C.
    Drimba, L.
    Sari, R.
    Szilvassy, Z.
    Nemeth, J.
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2014, 299 (01) : 157 - 164
  • [16] Description and application of a novel glucagon-like peptide-1 (GLP-1) radioimmunoassay
    B. Lelesz
    G. K. Tóth
    B. Peitl
    C. Hegedűs
    L. Drimba
    R. Sári
    Z. Szilvássy
    J. Németh
    Journal of Radioanalytical and Nuclear Chemistry, 2014, 299 : 157 - 164
  • [17] Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
    Ja'arah, Daria
    Al Zoubi, Mazhar Salim
    Abdelhady, Gamal
    Rabi, Firas
    Tambuwala, Murtaza M.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2021, 14
  • [18] STRUCTURE OF HUMAN GLP-1 (GLUCAGON-LIKE PEPTIDE-1) CONTAINING PEPTIDES
    ORSKOV, C
    KOFOD, H
    RABENHOJ, L
    WETTERGREN, A
    HOLST, JJ
    REGULATORY PEPTIDES, 1992, 40 (02) : 223 - 223
  • [19] Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1)
    Ang, Richard
    Mastitskaya, Svetlana
    Hosford, Patrick S.
    Basalay, Marina
    Specterman, Mark
    Aziz, Qadeer
    Li, Yiwen
    Orini, Michele
    Taggart, Peter
    Lambiase, Pier D.
    Gourine, Andrey
    Tinker, Andrew
    Gourine, Alexander V.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2018, 11 (10): : e006740
  • [20] Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders
    Wroge, Jamie
    Williams, Nancy Toedter
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (12) : 1041 - 1050
12345